Abstract

BackgroundThis study is to distinguish peripheral lung cancer and pulmonary inflammatory pseudotumor using CT-radiomics features extracted from PET/CT images.MethodsIn this study, the standard 18F-fluorodeoxyglucose positron emission tomography/ computed tomography (18 F-FDG PET/CT) images of 21 patients with pulmonary inflammatory pseudotumor (PIPT) and 21 patients with peripheral lung cancer were retrospectively collected. The dataset was used to extract CT-radiomics features from regions of interest (ROI), The intra-class correlation coefficient (ICC) was used to screen the robust feature from all the radiomic features. Using, then, statistical methods to screen CT-radiomics features, which could distinguish peripheral lung cancer and PIPT. And the ability of radiomics features distinguished peripheral lung cancer and PIPT was estimated by receiver operating characteristic (ROC) curve and compared by the Delong test.ResultsA total of 435 radiomics features were extracted, of which 361 features showed relatively good repeatability (ICC ≥ 0.6). 20 features showed the ability to distinguish peripheral lung cancer from PIPT. these features were seen in 14 of 330 Gray-Level Co-occurrence Matrix features, 1 of 49 Intensity Histogram features, 5 of 18 Shape features. The area under the curves (AUC) of these features were 0.731 ± 0.075, 0.717, 0.748 ± 0.038, respectively. The P values of statistical differences among ROC were 0.0499 (F9, F20), 0.0472 (F10, F11) and 0.0145 (F11, Mean4). The discrimination ability of forming new features (Parent Features) after averaging the features extracted at different angles and distances was moderate compared to the previous features (Child features).ConclusionRadiomics features extracted from non-contrast CT based on PET/CT images can help distinguish peripheral lung cancer and PIPT.

Highlights

  • This study is to distinguish peripheral lung cancer and pulmonary inflammatory pseudotumor using CT-radiomics features extracted from 18F-fluorodeoxyglucose positron emission tomography/ computed tomography (PET/CT) images

  • Lung cancer is the world’s leading cause of cancerrelated deaths and a highly malignant tumor [1, 2], According to the location of the tumor, lung cancer can be divided into peripheral lung cancer and central lung cancer, and more than 70% of all lung cancers are peripheral lung cancer [3]. lung cancer can be divided into adenocarcinoma, squamous cell carcinoma, small cell lung cancer and large cell lung cancer depending on the histological and cytological types of tumors

  • The results of this study indicated that there was a statistically significant difference between the radiomic features extracted from patients with peripheral lung cancer and those extracted from patients with pulmonary inflammatory pseudotumor (PIPT)

Read more

Summary

Introduction

This study is to distinguish peripheral lung cancer and pulmonary inflammatory pseudotumor using CT-radiomics features extracted from PET/CT images. The cumulative increase in metabolic activity of inflammatory cells will lead to an increase in FDG uptake, which is false positive on PET-CT. To some extent, these lesions can mimic the biological behavior of malignant tumors. Even if experienced nuclear medicine physicians manage to distinguish between benign and malignant FDG uptake, The result is still far from satisfactory This is a great challenge for clinicians and nuclear medicine doctors, such as the differentiation of pulmonary inflammatory pseudotumor (PIPT) and peripheral lung cancer [14, 15]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call